B
BIIB icon

Bailard’s Biogen BIIB Stock Holding History

Bailard’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-877
Closed -$248K – 725
2021
Q3 		$248K Buy
+877
New +$287K 0.01% 606
2021
Q2 		– Sell
-1,611
Closed -$451K – 709
2021
Q1 		$451K Hold
1,611
– – 0.02% 417
2020
Q4 		$394K Buy
1,611
+12
+0.8% +$3.1K 0.02% 381
2020
Q3 		$454K Sell
1,599
-189
-11% -$52.7K 0.02% 300
2020
Q2 		$478K Buy
1,788
+27
+2% +$8.12K 0.03% 274
2020
Q1 		$557K Buy
1,761
+138
+9% +$41.9K 0.04% 217
2019
Q4 		$482K Sell
1,623
-1
-0.1% -$277 0.03% 292
2019
Q3 		$378K Buy
1,624
+150
+10% +$34.9K 0.02% 347
2019
Q2 		$345K Buy
1,474
+55
+4% +$12.7K 0.02% 378
2019
Q1 		$335K Sell
1,419
-856
-38% -$270K 0.02% 393
2018
Q4 		$685K Buy
2,275
+85
+4% +$27.1K 0.05% 251
2018
Q3 		$774K Sell
2,190
-301
-12% -$104K 0.05% 243
2018
Q2 		$723K Buy
2,491
+460
+23% +$129K 0.04% 263
2018
Q1 		$556K Buy
2,031
+757
+59% +$235K 0.04% 300
2017
Q4 		$406K Buy
+1,274
New +$409K 0.03% 337
2016
Q4 		– Sell
-5,056
Closed -$1.58M – 306
2016
Q3 		$1.58M Buy
5,056
+2,723
+117% +$806K 0.15% 134
2016
Q2 		$564K Buy
+2,333
New +$615K 0.07% 189
2016
Q1 		– Sell
-2,200
Closed -$674K – 261
2015
Q4 		$674K Buy
+2,200
New +$632K 0.3% 111

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bailard's BIIB Position: Q4 2021 in Review

Bailard sold out of Biogen (BIIB) in Q4 2021, closing a stake of 877 shares — an estimated $248K sold.

Bailard first reported a position in BIIB in Q4 2015 and held it in 18 quarters. The position peaked at $1.58M in Q3 2016. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Bailard reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Bailard sold 877 Biogen shares in Q4 2021, an estimated $248K.
  • Bailard first reported a position in Biogen in Q4 2015 and held it in 18 quarters.
  • Bailard's Biogen position peaked at $1.58M in Q3 2016.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Bailard's 13F filing for Q4 2021, filed 10 Feb 2022.